Sigyn Therapeutics (SIGY) Prepaid Assets (2016 - 2025)
Sigyn Therapeutics (SIGY) posted Prepaid Assets of $1300.0 for Q2 2025, down 97.64% sequentially from $55200.0 in Q1 2025, and down 96.96% YoY from $42732.0 in Q2 2024.
Sigyn Therapeutics (SIGY) Prepaid Assets (2016 - 2025) Analysis & Trends
Sigyn Therapeutics has reported Prepaid Assets for 8 years, with the latest figure at $1300.0 in Q2 2025.
- Quarterly Prepaid Assets fell 96.96% year-over-year to $1300.0 in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $1300.0 (down 96.96% YoY) and the FY2024 annual result came in at $9100.0, down 83.86% from the prior year.
- Prepaid Assets slipped to $1300.0 in Q2 2025 per SIGY's latest filing, from $55200.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $56373.0 in Q4 2023 and troughed at $1300.0 in Q2 2025.
- A 5-year average of $32725.1 and a median of $40161.0 in 2023 frame the typical range for Prepaid Assets.
- The sharpest annual moves came in 2023 and 2025: Prepaid Assets jumped 648.37% in 2023, then slumped 96.96% in 2025.
- Over 5 years, Prepaid Assets stood at $2075.0 in 2021, then surged by 475.52% to $11942.0 in 2022, then surged by 372.06% to $56373.0 in 2023, then tumbled by 83.86% to $9100.0 in 2024, then sank by 85.71% to $1300.0 in 2025.
- According to Business Quant data, Prepaid Assets over the past three periods registered $1300.0, $55200.0, and $9100.0 for Q2 2025, Q1 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1,300.00 |
| Mar 31, 2025 | 55,200.00 |
| Dec 31, 2024 | 9,100.00 |
| Sep 30, 2024 | 54,320.00 |
| Jun 30, 2024 | 42,732.00 |
| Mar 31, 2024 | 51,590.00 |
| Dec 31, 2023 | 56,373.00 |
| Sep 30, 2023 | 54,287.00 |
| Jun 30, 2023 | 55,162.00 |
| Mar 31, 2023 | 40,161.00 |
| Dec 31, 2022 | 11,942.00 |
| Sep 30, 2022 | 7,254.00 |
| Jun 30, 2022 | 47,706.00 |
| Mar 31, 2022 | 12,245.00 |
| Dec 31, 2021 | 2,075.00 |
| Sep 30, 2021 | 27,509.00 |
| Jun 30, 2021 | 27,370.00 |
| Sep 30, 2018 | 2,500.00 |
| Jun 30, 2018 | 6,250.00 |
| Mar 31, 2018 | 10,334.00 |